Buy medical suite Singapore

Researched and written 2026-09-29 13:54 SGT · 15 sources listed at the end · draft 1 · figures verified against the named sources on the date shown; where a source has since moved, the element carries a marker.

What a medical suite actually is

A medical suite is a commercial strata unit built or fitted for a licensed clinic: medical-grade plumbing and electrical capacity, higher floor loading for imaging equipment, clinical-grade air filtration, a dedicated patient drop-off, sometimes a dedicated lift. That build-out is the whole premium over an ordinary office or retail unit — you are buying specification an empty shell doesn't have, and paying for the compliance risk it removes.

Supply is genuinely scarce. Singapore holds roughly 1,400 to 1,600 medical suites in total. About 1,000 sit inside hospital-linked buildings — Gleneagles Medical Centre, Mount Elizabeth Medical Centre, Mount Elizabeth Novena, Farrer Park Medical Centre, Paragon Medical — where ownership or occupation is restricted to licensed medical practitioners. The remaining 400 to 600 are open-market units any investor may buy. Annual transaction volume across the whole segment runs at only about 20 to 30 deals a year, and outright capital-gains resale is reported as 'very rare' — most owners hold to practise, not to flip.

Prices reflect that scarcity, not the residential cycle. Medical suite prices rose about 52% across Singapore between 2007 and 2018, against roughly 24% for private residential over a comparable stretch — District 11 (Novena, Thomson, Newton), the country's densest medical cluster, grew about 98% over the period. Current asking prices: around S$5,100 psf at Novena Medical Center, S$7,100–7,500 psf at Connexion and other Farrer Park medical-precinct addresses. Gross yields are reported at 3.5–5.5% for medical suites generally, with a premium strata unit in Novena marketed above 4%.

Eligibility: who may buy, and who may practise

Two separate gates sit on top of each other and people confuse them constantly. The first is ownership: can you buy the unit at all. The second is licensing: can a clinic legally operate inside it. Passing the first tells you nothing about the second.

Ownership is mostly a private building covenant, not a government rule. Novena Medical Centre is reported to permit non-practitioner investors to buy and hold a unit purely for rental income; Gleneagles Medical Centre and Mount Elizabeth Novena are reported to restrict ownership to licensed medical practitioners. A building can be — and often is — more restrictive than the law requires. Check the specific development's by-laws and management corporation rules before you assume you may buy as a pure investor.

Historically, medical suites were bought by practising doctors and medical groups, not passive investors — the ownership-by-practitioner model lets the doctor control big-ticket costs like operating-theatre rental rather than paying rent to an unrelated landlord. That history still shapes who a seller expects to be dealing with, even in buildings that formally allow investor ownership.

Licensing is separate and unavoidable. A clinic offering Outpatient Medical Service — the category an ordinary GP or specialist practice falls under — needs a Healthcare Services Act (HCSA) licence before it may operate at all, regardless of who owns the unit. The licensee may be a company or a natural person; there's no requirement the licensee hold clinical qualifications, though for a small solo practice the licensee is commonly the doctor who owns and practises there, taking on the Principal Officer and Clinical Governance Officer roles personally. Most healthcare businesses nonetheless incorporate for liability protection, in which case the company — not the individual doctor — holds the licence.

The HCSA licence is not transferable. On a sale of the clinic or the premises, the incoming operator must apply for and be granted a fresh licence — MOH assesses the premises, governance and service standards before granting it — and cannot lawfully treat patients at the address until that licence is issued. If you are buying a unit that already houses a clinic and plan to keep it running as one, budget time for this gap; you are not inheriting the seller's licence.

From November 2026, MOH's Health Regulation Group — licensing, inspections, audits and enforcement — moves to the Health Sciences Authority. If you're signing a lease or planning a purchase now, expect your regulator of record to change mid-transaction.

Zoning and the GFA quota — the ceiling nobody mentions until it bites

A private medical clinic doesn't need a site zoned Health & Medical Care (that zone is reserved for hospitals, polyclinics and nursing homes). It's an allowable use in a building zoned Commercial, Hotel, Commercial & Residential, Residential with 1st Storey Commercial, Business Park or Business-White, and in shophouses and HDB shops. Most medical suites — Novena Medical Center, the Farrer Park medical precinct — sit in ordinary commercial zoning, not a dedicated H&MC development.

URA circular DC14-28 (effective 23 December 2014) caps total medical-clinic floor area inside a commercial development at 3,000 sqm or 20% of the total floor area approved for commercial use, whichever is lower — to stop a building's shops, eateries and offices being crowded out by clinics. Below the lower of 1,000 sqm or 20% of commercial GFA, no URA planning application is needed for a new clinic; above it, a full planning permission application is required. Shophouses and HDB shops are exempt from the 20% test but stay capped at a flat 3,000 sqm. Clinics already over the cap when the circular took effect are grandfathered in.

This is where the two gates from the section above intersect. Before you rely on the sub-threshold exemption, or before you sign anything assuming a unit is clear to operate as a clinic, email MOH at MOH_Check_GFA@moh.gov.sg to verify how much of the building's clinic quota is already used. A unit can be zoned correctly and still be unable to legally house a clinic because the building's quota is full — and that is a fact about the building, not about your unit, so it can change after you buy if other tenants in the same block also convert to clinic use.

URA's 2014 circular also separates a medical centre — a concentration of many clinics under one roof — from a single dispersed clinic in an ordinary commercial building. A medical centre proper should sit on Health & Medical Care-zoned land; the GFA quota above governs the dispersed case, which is what most buyers of a strata medical suite are actually buying into.

Citizenship status: who pays what, and who needs approval to hold

A medical suite is commercial property, and this is where it diverges hardest from every residential page on this site. Nationality still matters, but not the way it does for a home.

• Singapore Citizen — buys freely, no approval needed, ordinary tax treatment below.
• Permanent Resident — buys freely, same as an SC for this asset class.
• Foreigner (any nationality) — buys freely too. SLA's foreign-ownership list states a foreign person may buy 'industrial and commercial properties' without approval, the same no-approval category as condominium and flat units. A medical suite is commercial use, so a foreign individual, company or trust needs no Land Dealings Approval Unit approval — unlike landed housing, vacant residential land, or a serviced apartment, all of which sit on SLA's approval-needed list.
• FTA nationals (US, Switzerland, Liechtenstein, Norway, Iceland) — the FTA parity rule that taxes them as citizens is an ABSD rule. It's moot here: see below.

The Residential Property Act's foreign-buyer approval regime — the one that stops most foreigners buying a landed house without special approval — reaches residential property only, by definition. A medical suite, being commercial, is entirely outside it, for every nationality. This is a genuine structural advantage of the asset class if you're a foreign buyer: no approval process, no waiting on the Land Dealings Approval Unit, no exceptional-economic-contribution test.

Taxes: the number that changes everything about this asset class

Additional Buyer's Stamp Duty does not apply to a medical suite, for any buyer — Singapore Citizen, PR, foreigner, company or trust all pay zero ABSD, the same position this site records for office, retail and industrial property. On a hypothetical S$3,000,000 unit, this is the up to S$1,950,000 an entity buyer would owe at the 65% ABSD (Trust/entity) rate on an equivalent residential purchase simply not existing here. It is the single largest cash difference between this asset class and a comparable-priced condo, and it means nobody needs to build a company structure purely to dodge ABSD the way one sometimes gets built for residential property — that reason for incorporating doesn't exist here.

Buyer's Stamp Duty still applies, on the higher of price or market value, at the same marginal bands as residential property: 1% on the first S$180,000, 2% on the next S$180,000, 3% on the next S$640,000, 4% on the next S$500,000, then 5% on everything above S$1.5m. There is no residential-only 6% top band for non-residential property — the marginal rate tops out at 5% above S$1.5m. On a S$3,000,000 medical suite this works out to roughly S$99,600 in BSD, computed on those bands.

Seller's Stamp Duty is reported as 'not applied' to this class of commercial space — unlike residential property, which carries a four-year SSD schedule, or industrial property, which carries its own separate SSD regime. Treat this as the commercial-property market convention this site applies elsewhere rather than a line read directly off a dated SSD schedule for medical suites specifically.

Property tax runs at the non-residential rate, since the unit is not your home — there's no owner-occupier concession the way there is for a residential property you live in, even if you're the practising doctor working there every day. GST is payable on top of price where the seller is GST-registered — in practice this usually means a developer or a GST-registered corporate seller, not a private individual doctor reselling their own unit. GST currently stands at 9%, having risen twice since an older 7% reference some guides still print. Rental income from letting a medical suite to a tenant clinic is ordinary taxable income for the landlord, same as any other commercial letting — GST applies to the rent itself once the landlord's taxable turnover crosses S$1 million a year and GST registration becomes mandatory.

CPF savings cannot fund any part of a medical suite purchase — not the price, not the downpayment, not legal fees. This applies regardless of whether you're buying to practise in it yourself or purely to let it out. Budget the entire transaction in cash and loan proceeds; CPF is not a lever here the way it is for a home.

Borrowing: LTV, TDSR, and why the bank you ask matters more than usual

There is no MAS-mandated loan-to-value ceiling on non-residential property the way there is on a home — MAS Notice 632's LTV table is a residential-property instrument. Banks set their own limit for a medical suite, and the range reported is genuinely wide: roughly 60–70% is described as typical underwriting in practice for strata commercial generally, against MAS Notice 645's 80% general non-residential-lending ceiling. Against that, one lender (HL Bank) markets financing 'for buying or refinancing a clinic or specialist medical suite' up to 90% LTV in its general offer, and up to 100% as a limited-period promotion — a single lender's own marketing claim, not a market figure to plan around. A separate guide reports up to 80% LTV available to a 'qualified business' buyer, with lenders wanting 2–3 years of financial history, an ACRA business profile and directors' credit reports on top of ordinary commercial-property underwriting. Get quotes from at least three banks; the spread between lenders on this asset class is unusually wide.

Total Debt Servicing Ratio still binds an individual borrower on a medical suite loan: 55% of gross monthly income, stress-tested at a 5% floor rate for non-residential property (against 4% for residential) regardless of the rate actually quoted. A company borrower is assessed differently — commonly on Debt Service Coverage Ratio, a 1.2–1.4x minimum, crediting up to 70% of gross monthly rent toward serviceable income where the unit is tenanted. Mortgage Servicing Ratio never applies here at all; MSR is specific to HDB flats and ECs.

At least one finance company markets a dedicated 'Medical & Dental Property Loan' for purchasing or refinancing a medical suite, open to a Singapore-registered entity, advertising high quantum and a legal-fee subsidy — but the page discloses no specific LTV, rate or tenure; those terms are quoted only on direct enquiry, so it establishes that medical-specific lending products exist, not what they actually cost you. Separately, a commercial loan-broker guide reports banks packaging a property/renovation loan (7–15 year tenure) together with separate medical-equipment financing (5–10 years) under one application for a healthcare practice — a worked example needed S$300,000–S$800,000 of total setup capital for a new clinic, of which S$200,000–S$600,000 was renovation, and banks commonly want rent to stay under about 15% of the clinic's projected revenue.

Fit-out, A&A, and the approvals stack — this page's expression of control

You cannot rebuild a strata medical suite the way you can a landed house — you own the unit, not the building, and the management corporation's by-laws govern what you may alter. Control here means fit-out: what you can do inside the four walls, and how fast you can get MOH and URA to let you use it as a clinic. That is a materially different, narrower lever than the reno/A&A/rebuild spectrum this site describes for landed property, and it's worth being clear-eyed about the difference before you buy expecting to reshape the asset.

A purpose-fitted unit already carries medical-grade plumbing and electrical capacity, clinical-grade air filtration, higher floor loading, higher ceilings for ceiling-mounted equipment, and a dedicated patient drop-off. Converting an ordinary commercial unit instead means retrofitting for soundproofing, enhanced ventilation, medical-waste disposal and infection-control compliance, on top of the URA and MOH approvals above — the tradeoff is a lower purchase price against a real renovation and risk bill, and a delay before you can open.

Fit-out cost planning references, not fixed quotes: a basic GP or TCM clinic from about S$60,000; a dental clinic from about S$120,000; an aesthetic or specialist clinic from about S$150,000. Per-square-foot guides disagree with each other — figures ranging roughly S$100 to S$380 psf depending on which guide and which clinic type — so budget from the itemised references rather than anchor on one psf number. Reported build timelines: about 6–8 weeks for a GP/TCM clinic, 8–12 weeks for dental, 10–14 weeks for an aesthetic or imaging clinic. MOH's medical-use-quantum clearance (the GFA quota above) should be checked before the fit-out design is locked, not after — redesigning a clinic layout because the quota check comes back negative is expensive and avoidable.

The approvals stack beyond the HCSA licence itself: BCA Building Works approval for structural, partition or M&E changes, including floor-loading reinforcement for heavy imaging equipment; an SCDF-registered Qualified Person submission and Fire Safety Certificate where the works touch compartment walls, exits, sprinklers or smoke detection; BCA accessibility requirements for patient routes; and a URA change-of-use lodgment if the unit wasn't already approved for clinic use — which is where the GFA quota becomes your problem as buyer, not the seller's.

Conveyancing and due diligence particular to this asset

Beyond ordinary conveyancing — Option to Purchase, Sale and Purchase Agreement, SLA lodgment, mortgage-side legal work — a medical suite buyer's due diligence carries two extra items no residential purchase needs. First, confirm with the seller and MOH how much of the building's clinic GFA quota is already used, in writing, before you exercise the option — a unit can look clear and still be blocked by other clinics already in the same building. Second, if you intend to keep an existing clinic running, start the fresh HCSA licence application early: it is not transferable, MOH inspects the premises before granting it, and you cannot lawfully treat patients until it's issued, which means a gap in operating income is a real possibility around completion, not a formality.

Buyer due diligence on the strata side should request the last three years of the management corporation's accounts and AGM minutes, to check sinking-fund adequacy, any planned common-area works, and the building's occupancy — commercial MCST maintenance is not regulated to the same standard as residential strata, and service-charge and sinking-fund levels vary widely by building age and specification. There is no government price index for medical suites specifically; URA's statistics cover office, retail and industrial space, not this asset class separately, so comparable transactions have to come from portal listings and agent knowledge rather than a published series.

Private conveyancing has no government-set fee schedule; lawyers price commercial purchase and mortgage-side work on their own terms, and a commercial deal — this is one — commonly falls outside the S$2,000–5,000 all-in range quoted for an ordinary private residential purchase. Get a specific quote for a commercial conveyancing scope rather than assume the residential range applies.

Estate: what happens to the practice when the doctor-owner dies

If you're a solo practitioner and the licensee, your death or incapacity doesn't just transfer an asset to your heirs — it stops the clinic operating, because the HCSA licence is personal to the licensee and not transferable. Your estate can inherit the unit through the ordinary succession route (will, or the Intestate Succession Act if there's no will), but whoever eventually operates a clinic in it — an heir, a buyer, a new tenant-doctor — needs a fresh licence, assessed and inspected by MOH from scratch. This is a materially different failure mode from a residential property or a passive commercial let: the asset and the business licensed to operate inside it are legally separate things, and only one of them passes by inheritance.

This is the practical argument for incorporating the practice rather than holding the HCSA licence personally: a company doesn't die. Shares in the practice company can pass to heirs or be sold while the company retains its own licence (subject to whatever change-of-control notification MOH requires), rather than the licence lapsing entirely on the founder's death. Weigh this against the cost and complexity of running a company, and against the fact that ABSD-avoidance — the usual reason to incorporate for residential property — isn't a reason here at all, since ABSD is already zero.

Property held in trust: the trustee, not the beneficiary, is entered as owner, and owner-occupier concessions don't apply where the trustee doesn't occupy the unit — moot for a medical suite anyway, since there's no owner-occupier property-tax concession on non-residential property regardless of trust structure. Transferring a property into a trust is a gift and counts as a transaction at an undervalue; if the settlor becomes unable to pay debts within three years of the transfer, the Official Assignee or a liquidator can claw it back.

THE VOICE — the twelve questions, on this purchase specifically

The two questions that actually sort you as a buyer aren't 'invest or stay' — nobody buys believing the price will fall, so that question sorts nobody. They're capital structure and income structure, asked plainly: are you borrowing to buy, and once you hold it, are you letting it out. A doctor buying cash to practise in it themselves gets pure appreciation with no carry. A doctor buying cash and letting it to another practitioner gets yield with positive carry by construction. Most owner-occupier doctors who borrow are carrying negative carry by construction and rarely say so out loud. Borrowing to buy and letting it out is the spread play — the gap between what the loan costs and what the tenant pays is the whole game.

C0 — The play

A medical suite you practise in yourself is a balance-sheet play with an operating business riding on top of it — the property appreciates or doesn't, separately from whether the clinic makes money. A medical suite you buy purely to let out to another doctor is closer to a cash-flow play: you're buying the rent stream and the scarcity premium, not a place to work.

C1 — Balance sheet

You gain an asset (the unit, at whatever it's worth) and, if you borrow, a matching liability (the loan). Unlike a home, there's no CPF-funded portion sitting inside the asset, and no ABSD cash locked in at entry — so the balance-sheet entry here is cleaner than a residential purchase: what you put in cash, plus what you borrowed, equals what you own.

C2 — Cash flow

Out: downpayment, BSD (~S$99,600 on a S$3m unit at current bands), legal fees, fit-out (S$60,000 to S$150,000+ depending on clinic type), loan instalments, property tax, MCST maintenance and sinking fund, GST if you're registered and letting commercially. In, if you let it: rent, which the market shows running roughly S$8 to S$38 psf a month depending on building and precinct — a very wide band, so get a real comparable, not the midpoint. The funding gap in year one is almost always the fit-out and the licence-application delay, not the mortgage — you may be paying instalments and maintenance for months before a licensed clinic (yours or a tenant's) is actually open and generating cash.

C3 — P&L

Not the same as cash flow. Depreciation-style wear on the fit-out, financing interest as an expense, and — if you're the operating doctor — the clinic's own revenue and costs all sit on the P&L, separately from what physically moved through your bank account this month. A profitable clinic can still be cash-poor in its first year because a chunk of that fit-out spend already happened; conversely a clinic can show a P&L loss (start-up costs, depreciation) while still being cash-flow positive if patients are paying promptly. Conflating the two is exactly the mistake that produces a liquidity squeeze nobody saw coming.

C4 — Carry

Rent (if let) minus financing cost. At reported gross yields of 3.5–5.5% against a mortgage rate materially above that on a highly-leveraged purchase, carry can be thin or negative even on a fully-tenanted unit — the yield compression at prime hospital-linked buildings specifically is reported to have pushed some buyers toward the 4%+ suburban alternative precisely because prime carry has gotten tighter as capital values rose.

C5 — Give / get

You give up liquidity, cash, and — if you're the operating doctor — flexibility to relocate quickly. You get scarcity-backed appreciation, a captive tenant pool if you let it (clinics relocate rarely, given the cost of moving a licensed practice and its patient base), and, if you occupy it, control over a big-ticket cost line (rent) that would otherwise go to an unrelated landlord.

C6 — Exposed to

Building-specific GFA quota changes (if other tenants convert to clinic use and fill the quota, your exit buyer may not be able to add another clinic); MOH regulatory transfer to HSA in November 2026 and whatever process friction that brings; interest-rate moves on a floating-rate commercial loan, which is more exposed than a residential mortgage since non-residential TDSR floors at 5%, not 4%; and tenant concentration if you let to a single clinic — a vacancy here can sit longer than a residential vacancy because the pool of clinic tenants for any one unit is small.

C7 — For how long

Medical tenants sign comparatively long leases — the cost and disruption of relocating a licensed clinic keeps churn low — so if you're a landlord, plan on a multi-year hold to actually realise that stability. If you're the operating doctor, the horizon is effectively your practising career, since exiting early means either selling with a licence gap for the buyer or finding a buyer who's also a licensed practitioner (in restricted buildings) or a willing tenant-operator (in open buildings).

C8 — Failure cascade

Negative carry (rent, if any, doesn't cover financing) hits cash flow first — you're topping up from salary or savings every month. That accumulates into the P&L as a running loss once fit-out amortisation and interest are counted. If it continues, the unit's equity position erodes as you either stop paying down principal or the asset's market value softens against a scarce, thin-transaction market (only 20–30 deals a year means a distressed sale finds few buyers fast). That produces illiquidity — you cannot exit quickly in a market this thin — which is the step that turns a carry problem into a forced-sale or insolvency problem, exactly in that order.

C9 — Liquidity

Poor, and this is the asset class's defining weakness. With only 20–30 transactions a year across the entire Singapore market, a forced or time-pressured sale means a real haircut — you are not selling into a deep, liquid market the way you would a mass-market condo. Building ownership restrictions (practitioner-only buildings) shrink your buyer pool further if you're in one of those.

C10 — Control

Confined and specific. You cannot rebuild or add area the way a landed owner can; your control lever is fit-out inside the four walls, subject to MCST by-laws, BCA and SCDF approvals, and the building's own remaining GFA quota. That quota is a building-level fact you don't control at all — another tenant converting to clinic use can close off your own expansion or your buyer's, regardless of what you do inside your unit.

C11 — The exit

Sell to another practitioner, an investor (where the building permits), or a corporate/medical-group buyer. Selling costs: BSD is a buyer cost not yours, but agent commission (commercial norm roughly 1–2% of price, negotiable, no CEA-prescribed rate), and — critically — the HCSA licence does not transfer with the sale, so your buyer inherits a licence-application gap you can't shorten for them. If GST-registered, you may owe GST on the sale itself. Budget a longer marketing period than a residential sale given the thin transaction volume. [⚠ shophouse.commission.commercial_norm_2026: sources differ; awaiting a ruling]

Buying through a company — the B2B route

Unlike residential property, buying a medical suite through a company gets you nothing on ABSD — it's already zero for an individual, so incorporating specifically to dodge the 65% entity ABSD rate that applies to residential purchases is simply not a consideration here. The real reasons to buy through a company are different and worth naming honestly.

• Liability protection for the practice, separate from your personal assets.
• Continuity — a company holding the HCSA licence doesn't die when the founding doctor does; shares can transfer or be sold, subject to MOH's change-of-control process, rather than the licence lapsing.
• Financing terms some lenders quote differently for a 'qualified business' — up to 80% LTV reported, against 2–3 years of financial history, ACRA profile and directors' credit checks as the price of that quantum.
• Debt-service assessment on DSCR rather than personal TDSR, which can suit a doctor whose personal income the bank would otherwise stress-test at the 55%/5%-floor residential-style rule.

The trade-off, stated plainly: a company structure costs money to run (ACRA filings, accounting, audit above certain thresholds), the HCSA licensee framework still needs a named Principal Officer and Clinical Governance Officer regardless of who owns the shares, and CPF still cannot touch any part of the purchase whether the buyer is you or your company. Incorporate for continuity and liability reasons if they matter to you — not because someone told you it saves tax on this asset class, because on ABSD specifically, it does not.

The realtor economics — what the agent earns, and where the incentive points

Commercial property agent commission on this asset class is reported at roughly 1% to 2% of price, negotiable, with no CEA-prescribed rate — the same absence of a fixed rate that applies to every other property type CEA regulates. CEA sets no rate and no guideline on amounts for any transaction type; the number on the table is whatever you and the agent agree, in writing, before the agent starts marketing. [⚠ shophouse.commission.commercial_norm_2026: sources differ; awaiting a ruling]

On a S$3,000,000 unit, each 1% of commission is S$30,000; at 2%, S$60,000, paid on completion out of sale proceeds, regardless of how the price compares to what the MCST's accounts or the building's remaining clinic-GFA quota might do to the unit's real usability. An agent is paid on the transaction closing, not on whether the unit turns out to be a good purchase for you — which is exactly why the GFA quota check, the MCST due diligence, and the licence-transferability point above are yours to verify, not something the commission structure incentivises the agent to chase down for you.

The agent cannot represent and collect commission from both buyer and seller in the same transaction — that's an offence under CEA rules, worth confirming explicitly before you sign anything. And by law, a property agent is prohibited from acting as a financial advisory representative under the Financial Advisers Act — precisely to stop an agent steering you toward a purchase decision that pays them more, versus a financing or investment structure that actually fits your situation. Any yield or price-appreciation claim an agent makes to you must be backed by verifiable comparable transaction data, not just told to you.

If you're already looking at the other side of this transaction

• Selling a medical suite: /sell/realty/medical-suite
• Letting one out as landlord: /landlord/realty/medical-suite
• Renting one as a tenant clinic: /tenant/realty/medical-suite
• Financing a purchase generally: /borrow
• The estate and succession questions in full: /estate
• Investing in commercial property as a route: /invest/for-investors

Sources

• URA — Private medical clinics in non-H&MC developments (2026-06-09) · https://www.ura.gov.sg
• URA — Circular DC14-28 / MOH Circular 35/2014 — change of use to medical clinics (2014-12-23) · https://www.ura.gov.sg
• MOH — Healthcare Services Act — regulation and licensing (2026-05-04) · https://www.moh.gov.sg
• MOH — HCSA licensee eligibility FAQ (2026-09-29) · https://ask.gov.sg
• IRAS — ABSD, BSD and property tax rates (2023-04-27) · https://www.iras.gov.sg
• SLA — Foreign ownership of property — approval-needed list (2025-08-20) · https://www.sla.gov.sg
• MAS — TDSR and MSR rules; non-residential LTV framework (2021-12-16) · https://www.mas.gov.sg
• CEA — Commission and agent conduct rules (2026-05-13) · https://www.cea.gov.sg
• PropertyLimBrothers — Medical suite investment guide (2026-09-29) · https://www.propertylimbrothers.com
• ZeroABSD.com — Novena medical suite pricing and yields (2026-09-01) · https://www.zeroabsd.com
• HL Bank — Clinic and medical suite financing (2026-09-29) · https://www.hlbank.com.sg
• Hong Leong Finance — Medical & Dental Property Loan (2026-09-29) · https://www.hlf.com.sg
• FixMove — Clinic fit-out cost guide (2026-09-29) · https://www.fixmove.sg
• CommercialGuru — Medical suite listings — sale and rent (2026-09-29) · https://www.commercialguru.com.sg
• EdgeProp — Medical suite ownership and pricing history (2016-09-02) · https://www.edgeprop.sg